FR
Search all our fact sheets and resources
Healthy pregnancy hub

Dextroamphetamine-Amphetamine (Adderall®)

Last Update: 21 May 2025

Welcome to our fact sheet on dextroamphetamine-amphetamine during pregnancy and breastfeeding/chestfeeding. This information is based on available published literature. It should not take the place of medical care and advice from your healthcare provider.

The HEALTHY PREGNANCY HUB team is collaborating with MotherToBaby to share information on this topic. The original version is available here (December 2023).

Serene, our chatbot, can also answer your questions about medications during pregnancy.

Please note that this fact sheet is based on United States information and has been adapted for Canada, with a review by our Canadian experts. Minor differences may exist between the two countries. Always consult your healthcare professional for information tailored to your situation.

1. What is dextroamphetamine-amphetamine?

Dextroamphetamine-amphetamine (Adderall®) is a combination prescription medication that has been used to treat attention deficit hyperactive disorder (ADHD) and narcolepsy (a condition that affects the brain’s ability to control sleeping and waking up). 

Sometimes when people find out they are pregnant, they think about changing how they take their medication, or stopping their medication altogether. However, it is important to talk with your healthcare providers before making any changes to how you take your medication. Stopping this medication suddenly can cause withdrawal in some people. It is not known if or how withdrawal may affect a pregnancy. If you are going to stop using this medication, your healthcare providers may talk with you about slowly reducing your dose over time. Your healthcare providers can also talk with you about the benefits of treating your condition and the risks of untreated illness during pregnancy. 

Dextroamphetamine-amphetamine is different from methamphetamine. MotherToBaby has a fact sheet on methamphetamine here: https://mothertobaby.org/fact-sheets/methamphetamine/. This sheet will focus on the use of dextroamphetamine-amphetamine under medical supervision. We have a fact sheet on dextroamphetamine here.

2. What does research say about the risks during pregnancy?

I take dextroamphetamine-amphetamine. Can it make it harder for me to get pregnant?

Taking prescribed dextroamphetamine-amphetamine as directed by your healthcare provider is not expected to make it harder to get pregnant. 

Does taking dextroamphetamine-amphetamine increase the chance of miscarriage?

Miscarriage is common and can occur in any pregnancy for many different reasons. Taking prescribed dextroamphetamine-amphetamine as directed by your healthcare provider is not expected to increase the chance of miscarriage. 

Does taking dextroamphetamine-amphetamine increase the chance of birth defects? 

Every pregnancy starts out with a 3-5% chance of having a birth defect. This is called the background risk. Most studies suggest that taking dextroamphetamine or amphetamine during the first trimester does not increase the chance of birth defects. In a large study of women taking stimulants for ADHD during pregnancy, there was no increased risk for birth defects reported when taking amphetamines, such as dextroamphetamine-amphetamine, for ADHD treatment. 

Does taking dextroamphetamine-amphetamine in pregnancy increase the chance of other pregnancy-related problems?

Although data is limited, when used as directed by a healthcare provider, taking dextroamphetamine-amphetamine during pregnancy has sometimes been associated with a higher chance of pregnancy-related problems, such as poor growth (babies born small and/or with a small head size), low birth weight (weighing less than 5 pounds, 8 ounces [2500 grams] at birth), or preterm delivery (birth before week 37). People taking dextroamphetamine-amphetamine may experience side effects from their medication, such as weight loss due to decreased appetite, changes in heart rate, and changes in blood pressure. Talk with your healthcare provider about monitoring these side effects to help improve outcomes for you and your baby. 

I need to take dextroamphetamine-amphetamine throughout my entire pregnancy. Will it cause withdrawal symptoms in my baby after birth?

It is not known if taking dextroamphetamine-amphetamine could cause withdrawal symptoms in a newborn after birth. This has not been well studied in people only taking dextroamphetamine-amphetamine as directed during pregnancy. 

Does taking dextroamphetamine-amphetamine in pregnancy affect future behavior or learning for the child?

Although limited by looking at all ADHD medications together, a Danish study suggested no increase in neurodevelopmental disorders, like ADHD, in the children of individuals who continued their ADHD medication during pregnancy versus those who stopped their medication before becoming pregnant. 

3. Breastfeeding​/ chestfeeding​ while taking dextroamphetamine-amphetamine

There are no studies on the combination of amphetamine-dextroamphetamine in breastfeeding/chestfeeding. Individually, amphetamine and dextroamphetamine have both been found to pass into breast milk / human milk. The effect of amphetamine in milk on behavior and brain development of infants has not been well studied. No adverse effects were reported in 4 infants (ages range from 3 months to 10 months) whose mothers were taking dextroamphetamine for ADHD. If you suspect the baby has any symptoms such as trouble eating, trouble sleeping, or irritability, contact the child’s healthcare provider. 

Some evidence suggests that large doses of dextroamphetamine could lower milk supply in people who are newly breastfeeding/chestfeeding. If you have any questions or concerns about breastfeeding/chestfeeding, talk with your healthcare provider, your baby’s pediatrician, or a lactation consultant. 

The product label for dextroamphetamine-amphetamine recommends people who are breastfeeding/chestfeeding not use this medication. But the benefit of using dextroamphetamine-amphetamine may outweigh possible risks. Your healthcare providers can talk with you about using dextroamphetamine-amphetamine and what treatment is best for you. Be sure to talk to your healthcare provider about all your breastfeeding/chestfeeding questions. 

4. What about fathers and sperm donors?

If a male takes dextroamphetamine-amphetamine, could it affect fertility or increase the chance of birth defects?

It is not known if dextroamphetamine-amphetamine could affect a male’s fertility (make it harder to get a person pregnant) or increase the chance of birth defects above the background risk.  In general, exposures that fathers or sperm donors have are unlikely to increase risks to a pregnancy. For more information, please see the MotherToBaby fact sheet Paternal Exposures here.

Key points

  • Dextroamphetamine-amphetamine (Adderall®) is a prescription medication used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy.
  • It is important not to stop or change this treatment without first talking to your healthcare provider.
  • When taken as prescribed, this medication does not appear to increase the risk of miscarriage or birth defects.
  • During pregnancy, it may be associated with a higher risk of low birth weight or preterm birth. However, research is limited.
  • Dextroamphetamine-amphetamine has not well been studied during breastfeeding or chestfeeding.
  • Always talk to your healthcare provider to discuss the benefits and risks of this treatment during pregnancy or while breastfeeding or chestfeeding.

References

Please click here to view references.

URL copied!

Disclaimer

HEALTHY PREGNANCY HUB provides a source of information validated by health professionals; however, this information is provided for informational purposes only and should not replace professional advice. Medical standards and practices evolve as new data becomes available, so it is imperative to consult your doctor or a qualified health professional for any questions or concerns regarding your health without delay or omission. It is the responsibility of your treating physician or any other health professional, based on their independent experience and knowledge of the patient, to determine the best way to evaluate and treat you.

HEALTHY PREGNANCY HUB does not specifically recommend or endorse any test, practitioner, treatment, product, or opinion mentioned on our platform. HEALTHY PREGNANCY HUB also does not replace the individual patient assessment based on the examination by the healthcare provider of each patient and the consideration of laboratory data and other patient-specific factors.

The use of the information available on our site is at your own risk. No person involved in the creation, production, promotion, or marketing of HEALTHY PREGNANCY HUB guarantees or represents, expressly or implicitly, anything regarding the information available on the platform, which is provided “as it is”. All warranties are expressly excluded and disclaimed, including but not limited to implied warranties of merchantability or fitness for a particular purpose, as well as any warranties arising by law or otherwise in law or from trade or usage. Any statements or representations made by any other person or entity are void.

While consulting symptoms or other medical information on our platform may guide your discussions with your healthcare professional, this information should not be used to make a medical diagnosis or determine treatment. Before making changes to your supplement or medication regimen, please discuss with your medical team or contact 811 (Canada) to ensure the relevance of these changes to your individual situation.

Credits
MotherToBaby
Organization of Teratology Information Specialists (OTIS)
View source
Catriona Hippman
University of British Columbia
Hilary Rowe
Fraser Health
Justine Pleau
University of Montreal
Émy Roberge
Centre hospitalier universitaire Sainte-Justine

Associated Fact Sheets

You want to know more about this topis? Discover our associated Fact Sheets!

Associated Resources

Want to know more? Discover our other contents associated to the topic.

Partners

Your pregnancy during COVID-19
uOttawa
University of Calgary
University of British Columbia
University of Saskatchewan
University of Manitoba
University of Alberta
Unité de soutien SSA
UDEM
Stratos
SOGC
RQRM
QTNPR
QPC
PWHR
Public Health Agency of Canada
PregMed France
SPOR
MPrint
Mitacs
Médicaments Grossesse
McGill
Médicament Québec
FRQ
Perinatal Network
CIHR
IQVIA
iPOP
Institut national de santé publique du Québec
INRS
Innovative Medicines Canada
IN-uTERO
Immerscience
Groww
Enrich
Design Develop Discover
CUSM
CIHR
CHU Sainte-Justine
Centre of Excellence on Partnership with Patients and the Public
CAN-AIM
Canadian Pharmacogenomics Network for Drug Safetry
CAMCCO
CAMCCO-L
C4T
BORN Ontario
Black Physicians of Canada
BC Children's Hospital
Alberta Health Services
MICYRN
UQAT
Dalhousie University